Literature DB >> 23117510

A description of telemental health services provided by the Veterans Health Administration in 2006-2010.

Tisha L Deen1, Linda Godleski, John C Fortney.   

Abstract

OBJECTIVE: This is the first large-scale study to describe the types of telemental health services provided by the Veterans Health Administration (VHA).
METHODS: The authors compiled national-level VHA administrative data for fiscal years 2006-2010 (October 1, 2005, to September 30, 2010). Telemental health encounters were identified by VHA and U.S. Department of Veterans Affairs stop codes and categorized as medication management, individual psychotherapy with or without medication management, group psychotherapy, and diagnostic assessment.
RESULTS: A total of 342,288 telemental health encounters were identified, and each type increased substantially across the five years. Telepsychotherapy with medication management was the fastest growing type of telemental health service.
CONCLUSIONS: The use of videoconferencing technology has expanded beyond medication management alone to include telepsychotherapy services, including both individual and group psychotherapy, and diagnostic assessments. The increase in telemental health services is encouraging, given the large number of returning veterans living in rural areas.

Mesh:

Year:  2012        PMID: 23117510     DOI: 10.1176/appi.ps.201100458

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  9 in total

1.  A pilot project to improve access to telepsychotherapy at rural clinics.

Authors:  Geri Adler; Lonique R Pritchett; Michael R Kauth; Danielle Nadorff
Journal:  Telemed J E Health       Date:  2013-10-29       Impact factor: 3.536

2.  The impact of telemental health use on healthcare costs among commercially insured adults with mental health conditions.

Authors:  Xiaohui Zhao; Sandipan Bhattacharjee; Kim E Innes; Traci J LeMasters; Nilanjana Dwibedi; Usha Sambamoorthi
Journal:  Curr Med Res Opin       Date:  2020-08-07       Impact factor: 2.580

Review 3.  Telepsychiatry Today.

Authors:  Steven Chan; Michelle Parish; Peter Yellowlees
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

4.  A randomized trial of Web-based videoconferencing for substance abuse counseling.

Authors:  Van L King; Robert K Brooner; Jessica M Peirce; Ken Kolodner; Michael S Kidorf
Journal:  J Subst Abuse Treat       Date:  2013-09-12

5.  Facility and state-level factors associated with telemental health (TMH) adoption among mental health facilities in the United States.

Authors:  Xiaohui Zhao; Kim E Innes; Sandipan Bhattacharjee; Nilanjana Dwibedi; Traci M LeMasters; Usha Sambamoorthi
Journal:  J Telemed Telecare       Date:  2019-09-02       Impact factor: 6.184

6.  Feasibility of a COVID-19 Rapid Response Telehealth Group Addressing Older Adult Worry and Social Isolation.

Authors:  Rachel Weiskittle; William Tsang; Anne Schwabenbauer; Nathaniel Andrew; Michelle Mlinac
Journal:  Clin Gerontol       Date:  2021-04-17       Impact factor: 2.619

7.  Bridging Care Gaps: Using Tele-health to Provide Care for People With Autism Spectrum Disorder.

Authors:  Felissa P Goldstein; Cheryl Klaiman; Sherrie Willliams
Journal:  Int J Dev Disabil       Date:  2017-10-03

8.  Mental health stigma and barriers to care in World Trade Center responders: Results from a large, population-based health monitoring cohort.

Authors:  Jonathan DePierro; Sandra M Lowe; Peter T Haugen; Leo Cancelmo; Jamie Schaffer; Clyde B Schechter; Christopher R Dasaro; Andrew C Todd; Michael Crane; Benjamin J Luft; Jacqueline M Moline; Denise Harrison; Iris G Udasin; Adriana Feder; Steven M Southwick; Robert H Pietrzak
Journal:  Am J Ind Med       Date:  2020-11-25       Impact factor: 2.214

9.  Protocol for a sequential, multiple assignment, randomised trial to test the effectiveness of message-based psychotherapy for depression compared with telepsychotherapy.

Authors:  Patricia Arean; Derrick Hull; Michael D Pullmann; Patrick J Heagerty
Journal:  BMJ Open       Date:  2021-11-02       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.